article thumbnail

Posner’s “judicial interpretive updating” and the disparagement clause (Best of 2017)

Likelihood of Confusion

Originally posted 2017-12-29 13:46:01. Republished by Blog Post PromoterOriginally posted on April 16, 2017. Thank God for small favors. Like being far away from the Seventh Circuit these days if you or your client want to rely on the words of a statute to determine what the law is.

article thumbnail

That great, free First Amendment thing (Best of 2017)

Likelihood of Confusion

First published July 24, 2017. The post That great, free First Amendment thing (Best of 2017) appeared first on LIKELIHOOD OF CONFUSION™. I was recently, and very briefly, the toast of whatever for my efforts in making the world safe for nasty trademark registrations under the banner.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Phantoms, zombies and the big problem with trademark use (Best of 2017)

Likelihood of Confusion

Originally published May 30, 2017. The post Phantoms, zombies and the big problem with trademark use (Best of 2017) appeared first on LIKELIHOOD OF CONFUSION™. I’ve got trademark use on the brain! Maybe it’s the Belmora effect — the result of living in a world in which use of a trademark in.

article thumbnail

Decoding the Ambiguity: Sun Pharma vs. Dabur India and the Uncertainty of Extensions of Time at the Opposition Evidence Stage under Trade Mark Rules, 2017

Selvam & Selvam Blog

The evolving landscape of the rules governing extensions of time at the evidence stage of opposition proceedings, particularly examining the transition from the Trade Marks Rules of 2002 (hereinafter “2002 Rules”) to the Trade Mark Rules 2017 (hereinafter “2017 Rules”) is a topic which has sparked significant debate recently.

article thumbnail

Arthrex Loses Bid For Director Review Of 2017 PTAB Ruling

IP Law 360

filed nearly two years ago seeking to have the director of the patent office review a 2017 decision invalidating claims of a suture patent. Saying the case has long been over, a Patent Trial and Appeal Board official has rejected requests that Arthrex Inc.

Patent 40
article thumbnail

Arthrex Asks USPTO Director To Review 2017 PTAB Decision

IP Law 360

itself to review a 2017 ruling invalidating two claims in a suture patent that were canceled by the USPTO in June. In the wake of the U.S. Supreme Court's Arthrex decision, the U.S. Patent and Trademark Office director has been asked by Arthrex Inc.

article thumbnail

Federal Circuit Appeals from the PTAB and ITC: Summaries of Key 2021 Decisions: Uniloc 2017 LLC v. Facebook Inc., 989 F.3d 1018 (Fed. Cir. 2021)

JD Supra Law

Facebook filed an inter partes review (IPR) petition against claims 1–8 of Uniloc 2017 LLC’s patent on Voice over Internet Protocol. Meanwhile, an IPR proceeding was already pending on claims 1–6 and 8 of the same patent, based on a petition filed by Apple and later joined by Facebook.

Patent 52